Shell Asset Management Co. Sells 2,286 Shares of Teladoc Health, Inc. (NYSE:TDOC)

Posted by on Feb 27th, 2023

Shell Asset Management Co. decreased its stake in shares of Teladoc Health, Inc. (NYSE:TDOC – Get Rating) by 18.8% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 9,851 shares of the health services provider’s stock after selling 2,286 shares during the period. Shell Asset Management Co.’s holdings in Teladoc Health were worth $250,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also modified their holdings of TDOC. Activest Wealth Management boosted its holdings in shares of Teladoc Health by 270.5% during the 3rd quarter. Activest Wealth Management now owns 678 shares of the health services provider’s stock worth $26,000 after buying an additional 495 shares during the period. SeaCrest Wealth Management LLC bought a new stake in shares of Teladoc Health during the 2nd quarter worth about $28,000. Quadrant Capital Group LLC boosted its holdings in shares of Teladoc Health by 23.3% during the 2nd quarter. Quadrant Capital Group LLC now owns 1,385 shares of the health services provider’s stock worth $46,000 after buying an additional 262 shares during the period. Wahed Invest LLC bought a new stake in shares of Teladoc Health during the 2nd quarter worth about $49,000. Finally, Avondale Wealth Management bought a new stake in shares of Teladoc Health during the 3rd quarter worth about $51,000. Institutional investors own 84.14% of the company’s stock.

Teladoc Health Stock Down 1.4 %

Shares of NYSE TDOC opened at $27.04 on Monday. The firm has a 50 day moving average price of $27.10 and a two-hundred day moving average price of $28.43. The company has a debt-to-equity ratio of 0.25, a quick ratio of 2.99 and a current ratio of 3.13. Teladoc Health, Inc. has a 52-week low of $21.60 and a 52-week high of $79.90.

Analyst Upgrades and Downgrades

TDOC has been the subject of several research analyst reports. Citigroup reduced their target price on shares of Teladoc Health from $36.00 to $33.00 and set a “neutral” rating for the company in a report on Tuesday, December 13th. SVB Securities raised shares of Teladoc Health from a “market perform” rating to an “outperform” rating and set a $34.00 price objective for the company in a report on Thursday. StockNews.com raised shares of Teladoc Health to a “sell” rating in a report on Friday. SVB Leerink raised shares of Teladoc Health from a “market perform” rating to an “outperform” rating and set a $34.00 price objective for the company in a report on Thursday. Finally, Credit Suisse Group cut their price objective on shares of Teladoc Health from $35.00 to $30.00 and set a “neutral” rating for the company in a report on Monday, October 31st. One equities research analyst has rated the stock with a sell rating, nineteen have issued a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $39.72.

Insider Activity at Teladoc Health

In other Teladoc Health news, insider Arnnon Geshuri sold 1,500 shares of Teladoc Health stock in a transaction dated Friday, February 3rd. The stock was sold at an average price of $31.82, for a total transaction of $47,730.00. Following the transaction, the insider now directly owns 74,317 shares of the company’s stock, valued at approximately $2,364,766.94. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other Teladoc Health news, insider Arnnon Geshuri sold 1,500 shares of the stock in a transaction that occurred on Friday, February 3rd. The shares were sold at an average price of $31.82, for a total transaction of $47,730.00. Following the completion of the sale, the insider now owns 74,317 shares of the company’s stock, valued at approximately $2,364,766.94. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Daniel Trencher sold 1,000 shares of the firm’s stock in a transaction that occurred on Friday, February 17th. The stock was sold at an average price of $30.21, for a total transaction of $30,210.00. Following the transaction, the senior vice president now owns 20,408 shares of the company’s stock, valued at approximately $616,525.68. The disclosure for this sale can be found here. Insiders sold 4,250 shares of company stock worth $127,240 over the last three months. Company insiders own 1.55% of the company’s stock.

Teladoc Health Company Profile

(Get Rating)

Teladoc Health, Inc engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. Its portfolio of services and solutions covers medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure.

Featured Stories

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.